Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain TFX message board posts where the ticker symbol TFX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest TFX SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000183 Size: 18 KB
2018-10-15
8-K  Documents Current report, item 2.03
Acc-no: 0000096943-18-000181 (34 Act)  Size: 22 KB
2018-10-11 001-05353
181117298
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000178 Size: 16 KB
2018-10-10
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000176 Size: 17 KB
2018-10-01
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000174 Size: 18 KB
2018-09-20
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000172 Size: 12 KB
2018-09-18
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000170 Size: 17 KB
2018-09-18
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000166 Size: 15 KB
2018-09-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000164 Size: 12 KB
2018-08-28
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000096943-18-000162 Size: 8 KB
2018-08-21
More TFX SEC Filings


Related news from
Mon, 15 Oct 2018
10:45:00 +0000
NeoTract Announces Data from New Real-World Study Demonstrating Excellent Results for UroLift® System Treatment for Enlarged Prostate
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the 2018 Annual Meeting of the Northeastern Section of the American Urology Association (AUA) in Toronto, Ontario, from a study of the company’s novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH). The real-world study, which enrolled 100 patients at a single center, evaluated the UroLift System treatment for lower urinary tract symptoms (LUTS) in men with BPH.
Thu, 11 Oct 2018
12:05:27 +0000
See what the IHS Markit Score report has to say about Teleflex Inc.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Mon, 08 Oct 2018
13:21:01 +0000
Teleflex's Latest Essential Medical Buyout to Broaden Suite
Teleflex (TFX) acquires Essential Medical to strengthen hold in the high-potential structural heart and endovascular aneurysm repair markets.
Thu, 04 Oct 2018
21:00:00 +0000
Teleflex Acquires Essential Medical
Teleflex Incorporated (TFX) today announced that it has acquired Essential Medical, Inc. Based in Exton, PA, Essential Medical is a privately-held medical device company that has developed and commercialized the CE Marked MANTA™ Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing devices or sheaths ranging in size from 10F to 18F (with maximum outer diameters up to 25F). “We are very excited to announce this acquisition, which expands our presence in the structural heart and endovascular aneurysm repair markets,” said Liam Kelly, President and Chief Executive Officer of Teleflex.
Wed, 26 Sep 2018
18:58:02 +0000
At US$271, Is It Time To Put Teleflex Incorporated (NYSE:TFX) On Your Watch List?
Today we’re going to take a look at the well-established Teleflex Incorporated (NYSE:TFX). The company’s stock saw a double-digit share price rise of over 10% in the past couple of<div><a class="permalink" href="https://simplywall.st/news/yahoo-post/at-us271-is-it-time-to-put-teleflex-incorporated-nysetfx-on-your-watch-list/">Read More...</a></div>
Wed, 26 Sep 2018
06:05:00 +0000
NeoTract Announces Results from Two Studies Demonstrating Transformative Benefits of the UroLift® System for BPH Care
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of Endourology 2018 Annual Conference from two U.K. studies of the company’s novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH). “This analysis of the UroLift System demonstrates its transformative impact on BPH care within a major health system,” said Dave Amerson, president of the NeoTract Interventional Urology business unit.
Wed, 26 Sep 2018
06:05:00 +0000
NeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift® System Treatment for Enlarged Prostate
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of Endourology 2018 Annual Conference from five studies of the company’s novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH). “The real-world results from these studies of diverse patient populations on three continents reaffirm the sustained benefits of the UroLift System as an accepted standard of care treatment for patients with BPH,” said Dave Amerson, president of the NeoTract Interventional Urology business unit.
Wed, 19 Sep 2018
11:00:44 +0000
5 Things to Know About Teleflex Stock
Shares of Teleflex (NYSE:TFX) are flat so far in 2018 thanks to a quick decline in early August — one that interrupted Teleflex stock’s more or less steady upward movement, which investors had enjoyed since 2011. For those less familiar, Teleflex is a medical technology company with vascular, surgical and anesthesia products –v85% of which it sells directly to hospitals and healthcare providers, according to TFX’s 2017 annual report. Teleflex stock has regained a lot of what was loss already, but it’s still down slightly from 52-week highs.
Mon, 17 Sep 2018
10:45:00 +0000
NeoTract Announces Multiple Data Presentations from Studies of UroLift® System Treatment for Enlarged Prostate at the World Congress of Endourology
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced that new clinical data from numerous studies of the UroLift® System for patients with benign prostatic hyperplasia (BPH) will be presented at the 36th World Congress of Endourology (WCE) 2018 Annual Conference taking place September 20-23 in Paris. The company also announced that co-founder and chief technical officer, Ted Lamson, Ph.D., co-inventor of the UroLift System, will be receiving the 2018 Industry Award for Innovations in Endourological Instrumentation from the Endourological Society.
Thu, 13 Sep 2018
10:45:00 +0000
Teleflex to Support Responding to Cardiac Arrest at ERC Congress, Resuscitation 2018, in Bologna, Italy from September 20th – 22nd
Teleflex Incorporated , a leading global provider of medical technologies for critical care and surgery, today announced that during the ERC Congress, it will focus on t
Mon, 10 Sep 2018
11:31:28 +0000
What Teleflex’s Valuation Trend Indicates
From January 2–28, 2018, Teleflex (TFX) stock rose from $254.73 to $287.65, which was its high point so far in 2018. During the broader market turmoil in February, it dipped to a low of $242.67 on March 1. Then it made a steady recovery to $280 in June but has corrected again to its current level of $248.
Fri, 07 Sep 2018
18:13:56 +0000
Analysts Still Bullish on Teleflex Stock
Teleflex’s (TFX) interest expenses increased from $19.89 million in the second quarter of 2017 to $26.65 million in the second quarter of 2018. Its income taxes, on the other hand, decreased from $12.1 million in the second quarter of 2017 to $9.58 million in the second quarter of 2018.
Fri, 07 Sep 2018
18:13:55 +0000
Analyzing Teleflex’s Top-Line Trend
Teleflex (TFX) is a global medical technology company that develops and commercializes medical devices for critical care and surgical applications. In June, Teleflex acquired certain assets of QT Vascular, a developer of coronary balloon catheters, for a consideration of $20.6 million. Teleflex generated total revenues of $609.9 million in the second quarter of 2018 compared to $528.6 million in Q2 2017.
Fri, 07 Sep 2018
18:13:55 +0000
Understanding Teleflex’s Operational Performance
Teleflex’s (TFX) geographic segments include the United States, Europe, Asia, and other. Teleflex incurred a total cost of sales of $265.09 million in the second quarter of 2018 compared to $238.3 million in the second quarter of 2017. For fiscal 2018, Teleflex’s gross margins are expected to be 57.56% compared to 55.76% for fiscal 2017.
Wed, 29 Aug 2018
10:45:00 +0000
Teleflex to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
Liam Kelly, President and CEO, Teleflex Incorporated , is scheduled to speak at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt in New York City, Wednesday, September 12, 2018 at 2:50 p.m.
Tue, 28 Aug 2018
10:30:00 +0000
Teleflex Announces First Patient Enrollment in Clinical Study Evaluating CleanSweep™ Closed Suction System’s Effects on Ventilator Mechanics Versus a Traditional Closed Suction Catheter
Teleflex Incorporated , a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep™ Closed Suction System at Duke University Hospital in Durham, NC.
Wed, 22 Aug 2018
10:45:00 +0000
Teleflex to Present at the Wells Fargo Securities 2018 Healthcare Conference
Liam Kelly, President and CEO, Teleflex Incorporated , is scheduled to speak at the Wells Fargo Securities 2018 Healthcare Conference at the Westin Copley Place in Boston, MA, Wednesday, September 5, 2018 at 4:10 p.m.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is an awesome community of bright, serious, passionate and involved individual investors. Information is well organized into fine-grained topics and discussions are always on topic and relevant. People here certainly know what value is and this site itself is a great reflection of that. I feel honored and privileged to have found such a great resource and to be part of it!" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards